Skip to content

The Future of Prostate Cancer Care is Here

Prostate Cancer Care at BAMF Health

At BAMF Health, we bring together advanced imaging, cutting-edge therapies, and world-class expertise to change what’s possible for men with prostate cancer.

Whether you’ve just been diagnosed with prostate cancer and want a second opinion or are exploring options beyond traditional treatments, we’re here to help you live longer and live better.

Let’s take the next step together.

A Prostate Cancer Center of Excellence

At BAMF Health, we don’t just treat prostate cancer — we redefine how it’s managed. We are the global leader in Theranostics, a combination of advanced molecular imaging and targeted radiopharmaceutical therapy.  We provide precise diagnosis, personalized treatment, advanced clinical trials, and compassionate care all under one roof.

You deserve more than hope. You deserve precision, comfort, and an expert care team fully dedicated to your journey.

What makes us different

  • Experts in metastatic prostate cancer care — our providers have decades of experience in radiation oncology and Theranostics.

  • Comprehensive care — from diagnosis to therapy and follow-up, guided by the same expert team.

  • Advanced technology — including the most advanced PET/CT scanner ever built, Michigan’s only PET/MR, and SPECT/CT imaging.

  • Access to clinical trials — offering novel radiopharmaceutical imaging and therapy trials treatments before they are widely available.

Michael's Story

Most Advanced PSMA PET/CT Scans

At BAMF Health, you have access to the most advanced PET scanner ever built. It not only finds cancer that traditional scanners miss, but also scans in less than 5 minutes.

This targeted imaging uses a radioactive tracer to identify a unique protein on prostate cancer cells called prostate specific membrane antigen (PSMA). Once the tracer binds to the proteins, it lights up, revealing the exact location of the cancer down to the millimeter.

Ask your doctor to order your PET scan at BAMF Health and you’ll:

  • Get in faster
  • Get scanned quicker
  • Get results sooner

Targeted Radiopharmaceutical Therapy

BAMF Health offers a PSMA-targeted radiopharmaceutical therapy called Pluvicto (177Lu-PSMA-617). This revolutionary treatment delivers radiation directly to prostate cancer cells while sparing healthy tissues. Most of our patients experience little to no side effects and can continue doing the things they love throughout their treatment journey.

Our facility was specifically designed to deliver these types of treatments. Each space you encounter is curated for administering radiopharmaceuticals efficiently, safely, and comfortably. It’s what we do best, and it shows.

Personalized Treatment with SPECT/CT

We follow a unique, beneficial treatment protocol using the GE StarGuide SPECT/CT scanner. Within 24 hours of every treatment cycle, patients return to BAMF Health for a SPECT/CT scan. This scan shows us exactly where the treatment is in your body and how hard it’s working. That same day, we review the results with you to identify how much cancer is left, where it’s located, and how many treatments you’ll need going forward.

If the cancer cells are no longer present, patients may be able to pause treatments, saving money, reducing radiation exposure, and preserving cycles for future use. It’s true precision medicine in action.

The SPECT/CT Difference

  • "It's remarkable! You could see where the cancer was after my first treatment. The cancer spots lit up. I can't wait for my next scan."
    Ella
  • "You see the magic on the screen the next day, and that's when you know things are really happening. It's like being on the Starship Enterprise!"
    Michael
  • "It's real-time monitoring of what's going on with the cancer. It's great to look at the scans side-by-side and compare to previous scans."
    Mark

What to Expect as a Patient

Before Treatment
  • Meet with our expert, Dr. Brandon Mancini, for a one-on-one consultation to discuss your health history, previous scans, and prior treatments
  • Schedule a PSMA PET scan at BAMF Health, if you haven’t had one already
  • Connect with a nurse navigator to receive education and a personalized treatment plan tailored to your needs
During Treatment
  • Treatment is delivered at the BAMF Health Molecular Therapy Clinic
  • Private patient rooms with individual bathrooms and access to natural light
  • Treatments are delivered every six weeks
  • Receive a SPECT/CT scan 24 hours after each treatment with a same-day follow-up appointment to discuss the results
  • Continued collaboration between BAMF and your healthcare teams
After Treatment Course
  • Continued collaboration between care teams
  • Follow-up appointments as needed for imaging and treatment needs
  • Access to our advanced clinical trials
  • You’ll always be part of the BAMF family!

Our Latest News

PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibition (ARPI) therapy and:
– are considered appropriate to delay taxane-based chemotherapy, or
– have received prior taxane-based chemotherapy
The most common side effects include fatigue, dry mouth, nausea, bone marrow suppression, and renal toxicity.